Inventor
Ian M. Bell
Inventor
Harleysville, PA, US
Overview
Patents· 63 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
B82YSpecific uses or applications of nanostructures1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
11,026,958Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors202110,870,630Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors202010,272,077Piperidinone carboxamide azaindane CGRP receptor antagonists20199,994,518Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof20189,926,285'Allosteric modulators of nicotinic acetylcholine receptors'20189,840,481'Allosteric modulators of nicotinic acetylcholine receptors'20179,833,448Piperidinone carboxamide azaindane CGRP receptor antagonists20179,499,545'Piperidinone carboxamide azaindane CGRP receptor antagonists'20169,499,541'Piperidinone carboxamide indane CGRP receptor antagonists'20169,409,916'Piperidinone carboxamide spirohydantoin CGRP receptor antagonists'20169,296,750'Spirolactam CGRP receptor antagonists'20169,227,973'Pyridine CGRP receptor antagonists'20169,227,972'Aliphatic spirolactam CGRP receptor antagonists'20168,993,588'Carboxamide heterocyclic CGRP receptor antagonists'20158,912,210'Piperidinone carboxamide azaindane CGRP receptor antagonists'20148,883,807'Piperidinone carboxamide indane CGRP receptor antagonists'20148,796,260'Imidazobenzazepine CGRP receptor antagonists'20148,765,759'Monocyclic CGRP receptor antagonists'20148,754,096'Piperidinone carboxamide azaindane CGRP receptor antagonists'20148,685,965'CGRP receptor antagonists'20148,507,477'3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists'20138,481,556'Piperidinone carboxamide azaindane CGRP receptor antagonists'20138,362,005'Monocyclic amide CGRP receptor antagonists'20138,173,655'Bicyclic anilide heterocyclic CGRP receptor antagonists'20128,163,752'Tricyclic anilide heterocyclic CGRP receptor antagonists'20128,148,390'Monocyclic anilide spirolactam CGRP receptor antagonists'20128,143,266'Aryl heterocyclic CGRP receptor antagonists'20128,133,891'Tricyclic anilide spirolactam CGRP receptor antagonists'20128,080,544'Prodrugs of CGRP receptor antagonists'20118,071,772'Spirolactam bicyclic CGRP receptor antagonists'20118,071,770'Spirohydantoin aryl CGRP receptor antagonists'20118,071,771'Bicyclic spirohydantoin CGRP receptor antagonists'20118,003,792'Bicyclic anilide spirolactam CGRP receptor antagonists'20117,989,624'Aryl spirolactam CGRP receptor antagonists'20117,968,540'Spirohydantoin tricyclic CGRP receptor antagonists'20117,951,795'Constrained spirocyclic compounds as CGRP receptor antagonists'20117,947,677'Spirolactam tricyclic CGRP receptor antagonists'20117,893,079'Substituted monocyclic CGRP receptor antagonists'20117,851,464'Spirolactam aryl CGRP receptor antagonists'20107,750,010'Tricyclic anilide spirohydantion CGRP receptor antagonists'20107,696,192'Tricyclic anilide spirolactam CGRP receptor antagonists'20107,659,300'Monocyclic anilide spirolactam CGRP receptor antagonists'20107,629,338'Substituted monocyclic CGRP receptor antagonists'20097,625,901'Substituted monocyclic CGRP receptor antagonists'20097,390,798'Carboxamide spirolactam CGRP receptor antagonists'20087,288,559'Carboxamide spirohydantoin CGRP receptor antagonists'20077,205,293'Benodiazepine spirohydantoin CGRP receptor antagonists'20077,202,251'Bicyclic anilide spirohydantoin CGRP receptor antagonists'20077,192,954'Monocyclic anilide spirohydantoin CGRP receptor antagonists'20077,189,722'Aryl spirohydantoin CGRP receptor antagonists'20076,441,017'Inhibitors of prenyl-protein transferase'20026,410,534'Inhibitors of prenyl-protein transferase'20026,358,985'Inhibitors of prenyl-protein transferase'20026,248,756'Inhibitors of farnesyl-protein transferase'20016,090,805'Tocolytic oxytocin receptor antagonists'20005,968,938'Piperazine oxytocin receptor antagonists'19995,939,414'Benzodiazepine hydrazide derivatives as inhibitors of HIV integrase'19995,939,439'Inhibitors of farnesyl-protein transferase'19995,760,054'Alpha IC adrenergic receptor antagonists'19985,756,497'Tocolytic oxytocin receptor antagonists'19985,718,912'Muscarine agonists'19985,691,323'Muscarine antagonists'19975,574,044'Muscarine antagonists'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2009Patents assigned to MERCK & CO INC (21)· patent assignee history
1996Based in North Wales, PA, US· patent location history
1997–2021Based in Harleysville, PA, US· patent location history
2002Based in Harleyville, PA, US· patent location history
2010–2021Patents assigned to MERCK SHARP & DOHME (40)· patent assignee history
2011–2016Patents assigned to BELL IAN M (18)· patent assignee history
2011–2013Patents assigned to STUMP CRAIG A (9)· patent assignee history
2011–2014Patents assigned to SELNICK HAROLD G (8)· patent assignee history
2016Based in Plainsboro, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 40 | 2010–2021 |
| MERCK & CO INC | 21 | 1996–2009 |
| BELL IAN Mself | 18 | 2011–2016 |
| STUMP CRAIG A | 9 | 2011–2013 |
| SELNICK HAROLD G | 8 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Harleysville, Pennsylvania, US | 58 | 1997–2021 |
| Plainsboro, New Jersey, US | 3 | 2016 |
| Harleyville, Pennsylvania, US | 1 | 2002 |
| North Wales, Pennsylvania, US | 1 | 1996 |